Cleveland Biolabs Inc (NASDAQ:CBLI) Quarterly Sentiment at [SentimentNumber]

June 26, 2018 - By Maria Fierro

Cleveland BioLabs, Inc. (NASDAQ:CBLI) Corporate Logo

Positions for Cleveland Biolabs Inc (NASDAQ:CBLI)

In Q1 2018 Cleveland Biolabs Inc (NASDAQ:CBLI) big money sentiment is 1, according to SEC filings. That’s the same 2017Q4’s as. only 5 investment managers increased and started new positions, while 5 reduced and sold stakes in Cleveland Biolabs Inc so the sentiment is neither positive nor negative. Funds own 484,369 shares, up from 441,233 shares in 2017Q4. Funds holding Cleveland Biolabs Inc in top 10 was flat from 0 to 0 for the same number . In total 4 funds closed positions, 1 reduced and 2 increased. Also 3 funds bought new Cleveland Biolabs Inc stakes.

Biggest Cleveland Biolabs Inc Shareholders

Bank Of America Corp De owns 100 shares in Cleveland Biolabs Inc as of Q1 2018. Cleveland Biolabs Inc’s shareholder Bank Of Montreal Can owns 31 shares as of Q1 2018. Blackrock Inc. reported 11,657 shares. Citadel Advisors Llc revealed 13,501 shares position in Cleveland Biolabs Inc. The Germany-based fund Deutsche Bank Ag looks positive on Cleveland Biolabs Inc, owning 4 shares.

Cleveland BioLabs, Inc., a biopharmaceutical company, develops novel approaches to activate the immune system and address various medical needs in the United States and the Russian Federation.The company has $28.58 million market cap. The companyÂ’s advanced product candidate is entolimod, a Toll-like receptor 5 agonist that is used to prevent death from acute radiation syndrome, and as an oncology drug.Last it reported negative earnings. It is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics naturally occurring lipopeptides of Mycoplasma, and activates NF-kB pro-survival and immunoregulatory signaling pathways; and Mobilan, a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand.

Ticker’s shares touched $2.53 during the last trading session after 0.39% change.Cleveland BioLabs, Inc. has volume of 10 shares. Since June 26, 2017 CBLI has declined 28.87% and is downtrending. CBLI underperformed by 41.44% the S&P 500.

The Minnesota-based Us Fincl Bank De has invested 0% in Cleveland BioLabs, Inc. (NASDAQ:CBLI). Bancorp Of America Corporation De invested in 100 shs or 0% of the stock. Susquehanna Interest Group Llp reported 11,987 shs. Renaissance Technology Ltd Liability Corp stated it has 0% in Cleveland BioLabs, Inc. (NASDAQ:CBLI). Stratos Wealth Limited has invested 0% in Cleveland BioLabs, Inc. (NASDAQ:CBLI). Bank Of Montreal Can reported 0% in Cleveland BioLabs, Inc. (NASDAQ:CBLI). Deutsche Natl Bank Ag invested in 4 shs or 0% of the stock. Citadel Lc invested in 13,501 shs. Wells Fargo & Company Mn has 150 shs for 0% of their capital. Geode Mngmt Lc invested in 0% or 16,688 shs. Grp One Trading Limited Partnership has 68 shs for 0% of their capital. Blackrock Incorporated stated it has 0% in Cleveland BioLabs, Inc. (NASDAQ:CBLI). Vanguard Group holds 170,347 shs.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.